Neuropsychological assessment in rare pediatric neurogenetic disorders: considerations for cross-cultural clinical research

References

• Achenbach, T. M. (2019). International findings with the Achenbach System of Empirically Based Assessment (ASEBA): Applications to clinical services, research, and training. Child and Adolescent Psychiatry and Mental Health, 13(1), 30. https://doi.org/10.1186/s13034-019-0291-2
   PubMedGoogle Scholar
• American Psychological Association. (2017). Ethical principles of psychologists and code of conduct ( 2002, amended effective June 1, 2010, and January 1, 2017). http://www.apa.org/ethics/code/index.html
   Google Scholar
• Aronson, K. J. (2006). Rare diseases and orphan drugs. British Journal of Clinical Pharmacology, 61(3), 243–245. https://doi.org/10.1111/j.1365-2125.2006.02617.x
   PubMed Web of Science ®Google Scholar
• Augustine, E. F., Adams, H. R., & Mink, J. W. (2013). Clinical trials in rare disease: Challenges and opportunities. Journal of Child Neurology, 28(9), 1142–1150. https://doi.org/10.1177/0883073813495959
   PubMed Web of Science ®Google Scholar
• Bayley, N., & Aylward, G. P. (2019). Bayley Scales of Infant and Toddler Development (4th ed.). Pearson.
   Google Scholar
• Bordes Edgar, V., Meneses, V., Shaw, D., Romero, R. A., Salinas, C. M., & Kissel, A. (2022). Clinical utility of the ECLECTIC framework in providing culturally-informed autism spectrum disorder evaluations: A pediatric case-based approach. The Clinical Neuropsychologist, 36(5), 1148–1171. https://doi.org/10.1080/13854046.2021.1936187
   PubMed Web of Science ®Google Scholar
• Bordes Edgar, V., & Romero, R. A. (2020). Culture and language diversity in pediatric neuropsychology. In O. Pedraza (Ed.), Clinical cultural neuroscience (pp. 215–232). Oxford University Press.
   Google Scholar
• Brown, A. K., Parikh, S., & Patel, R. D. (2020). Understanding basic concepts of developmental diagnosis in children. Translational Pediatrics, 9(S1), S9–S22. https://doi.org/10.21037/tp.2019.11.04
   PubMedGoogle Scholar
• Cable, J., Purcell, H. R., Robinson, E., Vorstman, S. A. J., Chung, K. W., Constantino, N. J., Sanders, J. S., Sahin, M., Dolmetsch, E. R., Shah, M. B., Thurm, A., Martin, L. C., Bearden, E. C., & Mulle, G. J. (2021). Harnessing rare variants in neuropsychiatric and neurodevelopment disorders—A Keystone Symposia report. Annals of the New York Academy of Sciences, 1506(1), 5–17. https://doi.org/10.1111/nyas.14658
   PubMed Web of Science ®Google Scholar
• Canas, A., Bordes Edgar, V., & Neumann, J. (2020). Practical considerations in the neuropsychological assessment of bilingual (Spanish-English) children in the United States: Literature review and case series. Developmental Neuropsychology, 45(4), 211–321. https://doi.org/10.1080/87565641.2020.1746314
   PubMed Web of Science ®Google Scholar
• Chelune, J. G., Naugle, I. R., Lüders, H., Sedlak, J., & Al, E. (1993). Individual change after epilepsy surgery: Practice effects and base-rate information. Neuropsychology, 7(1), 41–52. https://doi.org/10.1037/0894-4105.7.1.41
   Google Scholar
• Cohen, P. J., & Felix, A. (2014). Are payers treating orphan drugs differently? Journal of Market Access & Health Policy, 2(1), 23513. https://doi.org/10.3402/jmahp.v2.23513
   Google Scholar
• Colbert, A. M., Lamb, M. M., Asturias, E. J., Muñoz, F. M., Bauer, D., Arroyave, P., Hernández, S., Martínez, M. A., Paniagua-Avila, A., Olson, D., Calvimontes, D. M., Bolaños, G. A., El Sahly, H. M., & Connery, A. K. (2020). Reliability and validity of an adapted and translated version of the Mullen Scales of Early Learning (AT-MSEL) in rural Guatemala. Child: Care, Health and Development, 46(3), 327–335. https://doi.org/10.1111/cch.12748
   PubMed Web of Science ®Google Scholar
• Congress. (2022, December 28). Orphan drug act [Government]. U.S. Government Publishing Office. https://www.govinfo.gov/app/details/COMPS-980
   Google Scholar
• Delaney, A. K., Rudser, R. K., Yund, D. B., Whitley, B. C., Haslett, J. A. P., & Shapiro, G. E. (2014). Methods of neurodevelopmental assessment in children with neurodegenerative disease: Sanfilippo syndrome. JIMD Reports, 13, 129–137. https://doi.org/10.1007/8904_2013_269
   PubMedGoogle Scholar
• Elliott, C. D. (2007). Differential Ability Scales (2nd ed.). Harcourt Assessment.
   Google Scholar
• Farmer, C., Thurm, A., Troy, J. D., & Kaat, A. J. (2023). Comparing ability and norm-referenced scores as clinical trial outcomes for neurodevelopmental disabilities: a simulation study. Journal of Neurodevelopmental Disorders, 15(1), 4. https://doi.org/10.1186/s11689-022-09474-6
   PubMed Web of Science ®Google Scholar
• Fujii, M. E. D. (2018). Developing a cultural context for conducting a neuropsychological evaluation with a culturally diverse client: The ECLECTIC framework. The Clinical Neuropsychologist, 32(8), 1356–1392. https://doi.org/10.1080/13854046.2018.1435826
   PubMed Web of Science ®Google Scholar
• Goodspeed, K., Horton, D., Lowden, A., Sguigna, V. P., Booth, T., Wang, J. Z., & Edgar, B. V. (2022). A cross‐sectional natural history study of aspartylglucosaminuria. JIMD Reports, 63(5), 425–433. https://doi.org/10.1002/jmd2.12294
   PubMedGoogle Scholar
• Harder, L., Hernandez, A., Hague, C., Neumann, J., Mccreary, M., Cullum, M. C., & Greenberg, B. (2020). Home-based pediatric teleneuropsychology: A validation study. Archives of Clinical Neuropsychology, 35(8), 1266–1275. https://doi.org/10.1093/arclin/acaa070
   PubMed Web of Science ®Google Scholar
• Hill-Briggs, F., Dial, J., Morere, D., & Joyce, A. (2007). Neuropsychological assessment of persons with physical disability, visual impairment or blindness, and hearing impairment or deafness. Archives of Clinical Neuropsychology, 22(3), 389–404. https://doi.org/10.1016/j.acn.2007.01.013
   PubMed Web of Science ®Google Scholar
• Institute of Medicine (US) Committee on Accelerating Rare Diseases Research and Orphan Product Development. (2010). Rare diseases and orphan products: Accelerating research and development (M. J. Field & T. F. Boat, Eds.). National Academies Press (US). C, Medicare Part D Coverage and Reimbursement of Orphan Drugs. https://www.ncbi.nlm.nih.gov/books/NBK56190/?report=classic
   Google Scholar
• Janzen, D., Delaney, K. A., & Shapiro, E. G. (2017). Cognitive and adaptive measurement endpoints for clinical trials in mucopolysaccharidoses types I, II, and III: A review of the literature. Molecular Genetics and Metabolism, 121(2), 57–69. https://doi.org/10.1016/j.ymgme.2017.05.005
   PubMed Web of Science ®Google Scholar
• Judd, T., Capetillo, D., Carrion-Baralt, J., Marmol, M. L., Miguel-Montes, S. L., Navarrete, G. M., Puente, E. A., Romero, R. H., & Valdes, J. (2009). Professional considerations for improving the neuropsychological evaluation of hispanics: A national academy of neuropsychology education paper. Archives of Clinical Neuropsychology, 24(2), 127–135. https://doi.org/10.1093/arclin/acp016
   PubMed Web of Science ®Google Scholar
• Kaufman, A. S., & Kaufman, N. L. (2004). Kaufman Assessment Battery for Children (2nd ed.). American Guidance Service.
   Google Scholar
• Mindt, R. M., Byrd, D., Saez, P., & Manly, J. (2010). Increasing culturally competent neuropsychological services for ethnic minority populations: A call to action. The Clinical Neuropsychologist, 24(3), 429–453. https://doi.org/10.1080/13854040903058960
   PubMed Web of Science ®Google Scholar
• Mullen, E. M. (1995). Mullen Scales of Early Learning (AGS ed.). American Guidance Service Inc.
   Google Scholar
• National Cancer Institute, Division of Extramural Activities. (2017). The national cancer institute consumers’ cancer dictionary for peer review. National Cancer Institute. https://deainfo.nci.nih.gov/PeerReview/GuideCompleteBook.pdf
   Google Scholar
• Ozlu, C., Chelliah, P., Dahshi, H., Horton, D., Edgar, B. V., Messahel, S., & Kayani, S. (2022). ECHS1 deficiency and its biochemical and clinical phenotype. American Journal of Medical Genetics Part A, 188(10), 2908–2919. https://doi.org/10.1002/ajmg.a.62895
   PubMed Web of Science ®Google Scholar
• Rivera, D., Arango-Lasprilla, J. C., Arango-Lasprilla, J. C., & Rivera, D. (2017). Methodology for the development of normative data for Spanish-speaking pediatric populations. NeuroRehabilitation, 41(3), 581–592. https://doi.org/10.3233/NRE-172275
   PubMed Web of Science ®Google Scholar
• Roid, G. H. (2003). Stanford-Binet Intelligence Scales (5th ed.). Riverside Publishing.
   Google Scholar
• Roid, G. H., Miller, L. J., Pomplun, M., & Koch, C. (2013). Leiter International Performance Scale (3rd ed.). Stoelting Co.
   Google Scholar
• Rosselli, M., & Ardila, A. (2003). The impact of culture and education on non-verbal neuropsychological measurements: A critical review. Brain and Cognition, 52(3), 326–333. https://doi.org/10.1016/s0278-2626(03)00170-2
   PubMed Web of Science ®Google Scholar
• Savatt, M. J., & Myers, M. S. (2021). Genetic testing in neurodevelopmental disorders. Frontiers in Pediatrics, 9. https://doi.org/10.3389/fped.2021.526779
   PubMed Web of Science ®Google Scholar
• Shapiro, E., Bernstein, J., Adams, H. R., Barbier, A. J., Buracchio, T., Como, P., Delaney, K. A., Eichler, F., Goldsmith, J. C., Hogan, M., Kovacs, S., Mink, J. W., Odenkirchen, J., Parisi, M. A., Skrinar, A., Waisbren, S. E., & Mulberg, A. E. (2016). Neurocognitive clinical outcome assessments for inborn errors of metabolism and other rare conditions. Molecular Genetics and Metabolism, 118(2), 65–69. https://doi.org/10.1016/j.ymgme.2016.04.006
   PubMed Web of Science ®Google Scholar
• Shapiro, G. E., Escolar, L. M., Delaney, A. K., & Mitchell, J. J. (2017). Assessments of neurocognitive and behavioral function in the mucopolysaccharidoses. Molecular Genetics and Metabolism, 122, 8–16. https://doi.org/10.1016/j.ymgme.2017.09.007
   Web of Science ®Google Scholar
• Sparrow, S., Cicchetti, D., & Saulnier, C. (2016). Vineland adaptive behavior scales (3rd ed.). Pearson.
   Google Scholar
• U.S. Food and Drug Administration. (2019). Rare diseases: Natural history studies for drug development. Draft guidance for industry. https://www.fda.gov/regulatory-information/search-fda-guidance-documents/rare-diseases-natural-history-studies-drug-development
   Google Scholar
• van der Lee, J. H., Morton, J., Adams, H. R., Clarke, L., Ebbink, B. J., Escolar, M. L., Giugliani, R., Harmatz, P., Hogan, M., Jones, S., Kearney, S., Muenzer, J., Rust, S., Semrud-Clikeman, M., Wijburg, F. A., Yu, Z. F., Janzen, D., & Shapiro, E. (2017). Cognitive endpoints for therapy development for neuronopathic mucopolysaccharidoses: Results of a consensus procedure. Molecular Genetics and Metabolism, 121(2), 70–79. https://doi.org/10.1016/j.ymgme.2017.05.004
   PubMed Web of Science ®Google Scholar
• van der Lee, J. H., Morton, J., Adams, R. H., Clarke, L., Eisengart, B. J., Escolar, L. M., Giugliani, R., Harmatz, P., Hogan, M., Kearney, S., Muenzer, J., Muschol, N., Rust, S., Saville, R. B., Semrud-Clikeman, M., Wang, R., & Shapiro, E. (2020). Therapy development for the mucopolysaccharidoses: Updated consensus recommendations for neuropsychological endpoints. Molecular Genetics and Metabolism, 131(1–2), 181–196. https://doi.org/10.1016/j.ymgme.2020.08.007
   PubMed Web of Science ®Google Scholar
• Wakap, N. S., Lambert, M. D., Olry, A., Rodwell, C., Gueydan, C., Lanneau, V., Murphy, D., Cam, L. Y., & Rath, A. (2020). Estimating cumulative point prevalence of rare diseases: Analysis of the orphanet database. European Journal of Human Genetics, 28(2), 165–173. https://doi.org/10.1038/s41431-019-0508-0
   PubMed Web of Science ®Google Scholar
• Wechsler, D. (2012). Wechsler Preschool and Primary Scale of Intelligence, technical manual and interpretive manual (4th ed.). Psychological Corporation.
   Google Scholar
• Wechsler, D. (2014). Wechsler Intelligence Scale for Children, technical manual and interpretive manual (5th ed.). Pearson.
   Google Scholar
• Yang, G., Cintina, I., Pariser, A., Oehrlein, E., Sullivan, J., & Kennedy, A. (2022). The national economic burden of rare disease in the United States in 2019. Orphanet Journal of Rare Diseases, 17(1). https://doi.org/10.1186/s13023-022-02299-5
   Web of Science ®Google Scholar
• Zablotsky, B., Black, I. L., Maenner, J. M., Schieve, A. L., Danielson, L. M., Bitsko, H. R., Blumberg, J. S., Kogan, D. M., & Boyle, A. C. (2019). Prevalence and trends of developmental disabilities among children in the United States: 2009–2017. Pediatrics, 144(4), e20190811. https://doi.org/10.1542/peds.2019-0811
   PubMed Web of Science ®Google Scholar